Kura Oncology, Inc. Quarterly Debt-to-equity in % from Q1 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Kura Oncology, Inc. quarterly Debt-to-equity history and growth rate from Q1 2014 to Q3 2024.
  • Kura Oncology, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 11.4 %, a 33.6% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 11.4 +2.87 +33.6% Sep 30, 2024
Q2 2024 10.8 +3.07 +39.9% Jun 30, 2024
Q1 2024 10 +3.06 +44% Mar 31, 2024
Q4 2023 9.59 +3.44 +55.9% Dec 31, 2023
Q3 2023 8.55 +3.14 +58.1% Sep 30, 2023
Q2 2023 7.69 +2.65 +52.6% Jun 30, 2023
Q1 2023 6.95 +1.96 +39.3% Mar 31, 2023
Q4 2022 6.15 +0.87 +16.5% Dec 31, 2022
Q3 2022 5.4 -0.03 -0.55% Sep 30, 2022
Q2 2022 5.04 -1.26 -20% Jun 30, 2022
Q1 2022 4.99 -2.37 -32.2% Mar 31, 2022
Q4 2021 5.28 -3.26 -38.2% Dec 31, 2021
Q3 2021 5.43 -5.05 -48.2% Sep 30, 2021
Q2 2021 6.3 -3.73 -37.2% Jun 30, 2021
Q1 2021 7.35 -2.24 -23.3% Mar 31, 2021
Q4 2020 8.54 -1.28 -13% Dec 31, 2020
Q3 2020 10.5 +0.17 +1.65% Sep 30, 2020
Q2 2020 10 -0.55 -5.2% Jun 30, 2020
Q1 2020 9.6 -3.05 -24.1% Mar 31, 2020
Q4 2019 9.82 -2.78 -22.1% Dec 31, 2019
Q3 2019 10.3 -3.26 -24% Sep 30, 2019
Q2 2019 10.6 -5.12 -32.6% Jun 30, 2019
Q1 2019 12.7 -4.77 -27.4% Mar 31, 2019
Q4 2018 12.6 -7.86 -38.4% Dec 31, 2018
Q3 2018 13.6 -7.57 -35.8% Sep 30, 2018
Q2 2018 15.7 -7.37 -31.9% Jun 30, 2018
Q1 2018 17.4 -2.92 -14.4% Mar 31, 2018
Q4 2017 20.5 +4.86 +31.2% Dec 31, 2017
Q3 2017 21.2 +9.56 +82.5% Sep 30, 2017
Q2 2017 23.1 +13.2 +134% Jun 30, 2017
Q1 2017 20.3 +12.5 +160% Mar 31, 2017
Q4 2016 15.6 +6.02 +62.8% Dec 31, 2016
Q3 2016 11.6 -4.2 -26.6% Sep 30, 2016
Q2 2016 9.86 -7.18 -42.1% Jun 30, 2016
Q1 2016 7.82 -16.6 -68% Mar 31, 2016
Q4 2015 9.58 +146 Dec 31, 2015
Q3 2015 15.8 +123 Sep 30, 2015
Q2 2015 17 +124 Jun 30, 2015
Q1 2015 24.4 +135 Mar 31, 2015
Q4 2014 -137 Dec 31, 2014
Q3 2014 -107 Sep 30, 2014
Q2 2014 -107 Jun 30, 2014
Q1 2014 -110 Mar 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.